TBT is testing what it believes to be one of the more innovative and highly accurate solutions to rapid Covid-19 testing. The Company has developed a point of care, rapid, easy to use sensor that will detect COVID-19 from a cheek swab, giving an answer in under 10 minutes. Additionally, TBT is developing an antibody test to detect whether a person has been exposed to the virus. TBT will be issuing data on this website along with press releases shortly regarding this exciting work.

TBT biosensing applications include:

TBT’S Groundbreaking Biosensors Include: